脂多糖诱发肝损伤的分子机理和蛋白质组学研究
|
摘要
脂多糖(Lipopolysaccharide，LPS)是革兰氏阴性细菌内毒素的主要成分，也是革兰氏阴性细菌激发宿主免疫应答，导致机体损伤的重要因素。人体集聚革兰氏阴性杆菌最丰富的部位是肠道，其所产生的LPS经吸收首先到达肝脏，作为机体主要解毒器官的肝脏，无疑是清除LPS的最活跃场所，但也是免疫损伤的最常见靶位。LPS不但可加重肝硬化、酒精性肝病肝损伤，而且明显增强CCl_4和乙醇等肝毒性物质的肝毒性，单独LPS亦可导致肝损伤。但LPS引起肝损伤过程中涉及的具体信号转导分子及效应分子尚不清楚。
本研究运用常规分子生物学和免疫组织化学方法，动态分析LPS刺激不同时段肝脏LPS／TLR_4途径信号分子及功能分子TNF-α表达与肝脏病理变化的关系，同时比较LPS肝损伤发展不同时相蛋白质组变化，从蛋白质整体水平动态捕捉LPS肝损伤信号转导途径中的特异蛋白质“指纹”，搜查参与到该信号通道的信号、效应分子，探索LPS致肝损伤的发生机理。
首先，Balb／c鼠腹腔注射LPS建立急性内毒素血症动物模型，分别在3小时、6小时、12小时、24小时、30小时处死动物取肝脏组织，HE染色观察病理改变，免疫组织化学方法检测肝细胞凋亡
禾月组织TNF－a的表达，逆转录PCR（RT－PCR）法检狈肝组织信号
分子 1”LR。（Tolllike Receptor 4，TLR．）、MyD88（Myeloid
Differential Factor 88，MvD88）mRNA 7k平的表达。结果表明，
腹腔注射 LPS后 0、 小时小鼠一般情况无明显改变，肝组织学变
化不明显，24小时小鼠肝脏出现明显炎性浸润、坏死；而3～6 ’J’
时肝细胞凋亡和肝组织 TNF－口的表达达到高峰，12小时即明显减
少，24小时凋亡、坏死并存，以坏死为主；肝组织 TLR4mRNA的表
达在注射LPS后3小时开始下调，6、12小时明显抑制，24小时则
基本恢复：肝组织W088mRNA的表达在不同时间点变化不明显。
然后，本研究为探讨LPS诱发肝损伤相关蛋白质群的变化规
律，动态分析了LPS刺激不同时段肝脏的蛋白质谱型。在上述动物
实验基础上，匀浆抽提肝脏总蛋白进行双向凝胶电泳，从蛋白质表
达丰度角度，寻找差异表达蛋白质；对差异表达蛋白质斑点胰酶酶
解后用MALDITOF攸S作肽指纹图，结合蛋白质数据库搜索进行蛋
白质鉴定，并分析各差异蛋白质在内毒素肝损伤中的作用。结果
发现腹腔注射LPS后6 ’J’时（早期人 蛋白质谱显示TNF－a相关蛋
白TNFAIPI（TNF－a inducible endothelial protein，TNFAIPI）
表达明显上调，TRA IL受体2蛋白表达下调，线粒体相关蛋白
MetaxinZ、TIMMSA（Mitochondrlal import Inner membrane
translocase subunit TIMS A，TIMMSA）开始表达上调，部分蛋白
酶体相关蛋白质如磷脂酶AZ、PA28（proteasome activator 28，
PA28）、MDPP（Maggesiumdependent protein phosphatase，MDPP）
V
等的表达被抑制；24小时（后期，包括30小时3只小鼠死亡）的
蛋白质谱显示，TRAIL受体2表达抑制，线粒体相关蛋白MetaxinZ、
TIMMSA达到表达高峰，蛋白酶体相关蛋白磷脂酶AZ、PA28、MDPP
恢复表达，并开始表达增殖相关蛋白P34d＊激酶。
本研究结果提示，LPS致肝损伤呈时间依从性：早期，TNF－
a相关蛋白出现表达高峰，线粒体凋亡途径相关蛋白质开始表达上
调，出现以TNF－口为中心的肝细胞凋亡，肝组织TLR．mRNA的表达
表现为抑制状态；中后期，线粒体凋亡途径相关蛋白质达到表达高
峰，肝组织出现明显病理变化，凋亡和坏死并存，以坏死为主，同
时机体开始启动损伤修复程序，肝组织TLR．mRNA的表达开始恢复，
与肝脏的病理变化在时间上呈一致性，可能与LPS耐受性产生有关，
提示LPS信号传导分子TLR．在介导肝损伤中起重要作用，而
MmD88mRNA的表达在LPS刺激不同时限无明显变化，提示其为胞内
保守信号分子。
Bacterial infection is still a major threat to humans. Invasion of Gram-negative bacteria elicits immune responses, a major mediator of which is lipopolysaccharide(LPS), a component of the cell wall of Gram-negative bacteria. Liver is the first target organ to be attacked by the gut-derived lipopolysaccharide. LPS appears to provoke liver inflammation with focal hepatocyte injury and increases the sensitivity to CCU, ethanol liver injury. Recent study has shown that LPS can cause liver injury in normal subjects and exaggarate the liver injury in alcoholic liver disease. The prevailing hypothesis for LPS-induced signaling activation is that LPS/Toll-like receptor 4 (TLR4) signaling pathway is activated, proinflammatory factors are released and results in secondary tissue injury. However, the precise mechanism for LPS-induced liver injury remains unclear. It is conceivable that specific signaling and effector molecules are involved in the initiation and development of the processes.
In this study, signaling molecules involved in LPS/TLR4 signaling pathway and some effector molecules were detected by
molecular biological and immunohistochemistry technology at indicated timepoints in LPS-induced liver injury model. Simultaneously, the functional molecules involved in the pathogenesis of LPS-induced liver injury were detected by use of proteomics methods.
First, LPS-induced endotoxemic mouse were sacrificed at 3 hours, 6 hours, 12 hours, 24 hours and 30 hours respectively. The liver tissues were stained with hematoxylin and eosin for histopathologic analyses. Hepatocyte apoptosis and hepatic TNF-a was detected by immunohistochemical method. Simultaneously, the expression of TLR4mRNA and MyD88mRNA was detected by use of semi-quantitative RT-PCR. A large number of inflammatory cells infiltrated portal areas with additional focal hepatocellular necrosis 24 hours after i.p.LPS. Hepatocyte apoptosis and hepatic TNF- a expression increased significantly 3-6 hours after i.p LPS, while recruited to normal level at 12 hours. Hepatic TLR4mRNA expression was significantly depressed 6 through 12 hours after i.p.LPS, but recruited at 24 hours. Hepatic MyD88 mRNA expression did not change among different timepoints.
Second, we identified several possible target proteins in order to provide some information regarding the mechanism of LPS-induced liver injury. The total liver protein was separated by two-dimensional gel electrophoresis at indicated different timepoints. After in-gel tryptic
digestion, the peptide mass footprints were drawn up and the protein database was searched to identify the proteins. Then, analyzed how the indicated proteins participated in the pathogenesis of endotoxin-induced liver injury. After i.p. LPS: at earlier stage (6 hours), peak expression of TNFAIP1 was accompanied. TRAIL receptor 2 was downregulated. Mitochondrial related proteins (Metaxin2, TIMM8A) were upregulated. The proteasome related proteins were inhibited; Later stage (24 hours, even 3 mouse died at the 30 hour), significant histopathological changes took place with recruitment of proteasome related proteins and peak expression of metaxin2, TIMM8A . At the same time, p34 cdc2 kinase was also upregulated.
It was concluded that LPS-induced liver injury was time dependent. At earlier stage: TNF- a related proteins reached peak expression and mitochondrial apoptotic pathway related proteins began upregulating. TNF-a-dependent hepatocyte apoptosis played predominant role at this stage. The expression of liver TLR4mRNA was depressed significantly. At latter stage: Mitochondrial apoptotic pathway related proteins reached peak expression and the repair program was initiated at the appropriate timepoint. Hepatocyte necrosis made a major role at this stage. The expression of liver TLR4mRNA was recruited from the initial depressed states. It indicated that the signal molecule TLR4mRNA took an important role in LPS-induced
liver injury and may participated in LPS tolerance. MyD88mRNA expression di
本研究运用常规分子生物学和免疫组织化学方法，动态分析LPS刺激不同时段肝脏LPS／TLR_4途径信号分子及功能分子TNF-α表达与肝脏病理变化的关系，同时比较LPS肝损伤发展不同时相蛋白质组变化，从蛋白质整体水平动态捕捉LPS肝损伤信号转导途径中的特异蛋白质“指纹”，搜查参与到该信号通道的信号、效应分子，探索LPS致肝损伤的发生机理。
首先，Balb／c鼠腹腔注射LPS建立急性内毒素血症动物模型，分别在3小时、6小时、12小时、24小时、30小时处死动物取肝脏组织，HE染色观察病理改变，免疫组织化学方法检测肝细胞凋亡
禾月组织TNF－a的表达，逆转录PCR（RT－PCR）法检狈肝组织信号
分子 1”LR。（Tolllike Receptor 4，TLR．）、MyD88（Myeloid
Differential Factor 88，MvD88）mRNA 7k平的表达。结果表明，
腹腔注射 LPS后 0、 小时小鼠一般情况无明显改变，肝组织学变
化不明显，24小时小鼠肝脏出现明显炎性浸润、坏死；而3～6 ’J’
时肝细胞凋亡和肝组织 TNF－口的表达达到高峰，12小时即明显减
少，24小时凋亡、坏死并存，以坏死为主；肝组织 TLR4mRNA的表
达在注射LPS后3小时开始下调，6、12小时明显抑制，24小时则
基本恢复：肝组织W088mRNA的表达在不同时间点变化不明显。
然后，本研究为探讨LPS诱发肝损伤相关蛋白质群的变化规
律，动态分析了LPS刺激不同时段肝脏的蛋白质谱型。在上述动物
实验基础上，匀浆抽提肝脏总蛋白进行双向凝胶电泳，从蛋白质表
达丰度角度，寻找差异表达蛋白质；对差异表达蛋白质斑点胰酶酶
解后用MALDITOF攸S作肽指纹图，结合蛋白质数据库搜索进行蛋
白质鉴定，并分析各差异蛋白质在内毒素肝损伤中的作用。结果
发现腹腔注射LPS后6 ’J’时（早期人 蛋白质谱显示TNF－a相关蛋
白TNFAIPI（TNF－a inducible endothelial protein，TNFAIPI）
表达明显上调，TRA IL受体2蛋白表达下调，线粒体相关蛋白
MetaxinZ、TIMMSA（Mitochondrlal import Inner membrane
translocase subunit TIMS A，TIMMSA）开始表达上调，部分蛋白
酶体相关蛋白质如磷脂酶AZ、PA28（proteasome activator 28，
PA28）、MDPP（Maggesiumdependent protein phosphatase，MDPP）
V
等的表达被抑制；24小时（后期，包括30小时3只小鼠死亡）的
蛋白质谱显示，TRAIL受体2表达抑制，线粒体相关蛋白MetaxinZ、
TIMMSA达到表达高峰，蛋白酶体相关蛋白磷脂酶AZ、PA28、MDPP
恢复表达，并开始表达增殖相关蛋白P34d＊激酶。
本研究结果提示，LPS致肝损伤呈时间依从性：早期，TNF－
a相关蛋白出现表达高峰，线粒体凋亡途径相关蛋白质开始表达上
调，出现以TNF－口为中心的肝细胞凋亡，肝组织TLR．mRNA的表达
表现为抑制状态；中后期，线粒体凋亡途径相关蛋白质达到表达高
峰，肝组织出现明显病理变化，凋亡和坏死并存，以坏死为主，同
时机体开始启动损伤修复程序，肝组织TLR．mRNA的表达开始恢复，
与肝脏的病理变化在时间上呈一致性，可能与LPS耐受性产生有关，
提示LPS信号传导分子TLR．在介导肝损伤中起重要作用，而
MmD88mRNA的表达在LPS刺激不同时限无明显变化，提示其为胞内
保守信号分子。
Bacterial infection is still a major threat to humans. Invasion of Gram-negative bacteria elicits immune responses, a major mediator of which is lipopolysaccharide(LPS), a component of the cell wall of Gram-negative bacteria. Liver is the first target organ to be attacked by the gut-derived lipopolysaccharide. LPS appears to provoke liver inflammation with focal hepatocyte injury and increases the sensitivity to CCU, ethanol liver injury. Recent study has shown that LPS can cause liver injury in normal subjects and exaggarate the liver injury in alcoholic liver disease. The prevailing hypothesis for LPS-induced signaling activation is that LPS/Toll-like receptor 4 (TLR4) signaling pathway is activated, proinflammatory factors are released and results in secondary tissue injury. However, the precise mechanism for LPS-induced liver injury remains unclear. It is conceivable that specific signaling and effector molecules are involved in the initiation and development of the processes.
In this study, signaling molecules involved in LPS/TLR4 signaling pathway and some effector molecules were detected by
molecular biological and immunohistochemistry technology at indicated timepoints in LPS-induced liver injury model. Simultaneously, the functional molecules involved in the pathogenesis of LPS-induced liver injury were detected by use of proteomics methods.
First, LPS-induced endotoxemic mouse were sacrificed at 3 hours, 6 hours, 12 hours, 24 hours and 30 hours respectively. The liver tissues were stained with hematoxylin and eosin for histopathologic analyses. Hepatocyte apoptosis and hepatic TNF-a was detected by immunohistochemical method. Simultaneously, the expression of TLR4mRNA and MyD88mRNA was detected by use of semi-quantitative RT-PCR. A large number of inflammatory cells infiltrated portal areas with additional focal hepatocellular necrosis 24 hours after i.p.LPS. Hepatocyte apoptosis and hepatic TNF- a expression increased significantly 3-6 hours after i.p LPS, while recruited to normal level at 12 hours. Hepatic TLR4mRNA expression was significantly depressed 6 through 12 hours after i.p.LPS, but recruited at 24 hours. Hepatic MyD88 mRNA expression did not change among different timepoints.
Second, we identified several possible target proteins in order to provide some information regarding the mechanism of LPS-induced liver injury. The total liver protein was separated by two-dimensional gel electrophoresis at indicated different timepoints. After in-gel tryptic
digestion, the peptide mass footprints were drawn up and the protein database was searched to identify the proteins. Then, analyzed how the indicated proteins participated in the pathogenesis of endotoxin-induced liver injury. After i.p. LPS: at earlier stage (6 hours), peak expression of TNFAIP1 was accompanied. TRAIL receptor 2 was downregulated. Mitochondrial related proteins (Metaxin2, TIMM8A) were upregulated. The proteasome related proteins were inhibited; Later stage (24 hours, even 3 mouse died at the 30 hour), significant histopathological changes took place with recruitment of proteasome related proteins and peak expression of metaxin2, TIMM8A . At the same time, p34 cdc2 kinase was also upregulated.
It was concluded that LPS-induced liver injury was time dependent. At earlier stage: TNF- a related proteins reached peak expression and mitochondrial apoptotic pathway related proteins began upregulating. TNF-a-dependent hepatocyte apoptosis played predominant role at this stage. The expression of liver TLR4mRNA was depressed significantly. At latter stage: Mitochondrial apoptotic pathway related proteins reached peak expression and the repair program was initiated at the appropriate timepoint. Hepatocyte necrosis made a major role at this stage. The expression of liver TLR4mRNA was recruited from the initial depressed states. It indicated that the signal molecule TLR4mRNA took an important role in LPS-induced
liver injury and may participated in LPS tolerance. MyD88mRNA expression di
引文
[1] Manuel Perez-Ruiz, Josefa R., Manuel M-R, , et al. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide. Hepatology. 1999,29:1057-1063.
[2] Takehiko Uesugi, Matthias Froh, GavinE. Arteel, et al. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology. 2001,34:101-108.
[3] Rock, G. Hardiman, J. C. Timans, et al. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA. 1998,95:588.
[4] Takeuchi, O. T. Kawwai, H. Sanjo, et al. TLR6:a novel member of an expanding Toll-like receptor family. Gene. 1999,231:59.
[5] Tatsushi Muta & Koichiro Takeshige Essential roles of CD14 and lipopolysacharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4. Eur. J. Biochem. 2001,268:4580-4589.
[6] Ruey-Bing Yang, Melanie R. mark, Alane Gray, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature. 1998,395:284-288.
[7] Poltorak, A. X. He, I. Smirnova, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutants in Tlr4 gene. Science 282:2085.
[8] Hoshino, K., Takeuchi, O., Kawai, T., et al. (1999) Toll-like receptor 4(TLR4)-deficient mice are hyporesponsive to lipopolysacharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162,3749-3752.
[9] Takeuchi, O., Hoshino, K., Kawai, T., et al. (1999) Differetial roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11,443-451.
[10] Muzio, M. et al. Differential expression and regulation of Toll-like receptors in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164,5998-6004(2000).
[11] Lena Alexopoulou, Agnieszka Czopik Holt, Ruslan Medzhitov, et al. (2001) Recognition of double-stranded RNA and activation of NF-к B by Toll-like receptor 3. Nature. 413:732-738.
[12] Burns K., ClatworthyJ., Martin L, et al. Tollip, a new component of the IL-R1 pathway, links IRAK to the IL-1 receptor. Nat Cell Biol 2000,2:346-351.
[13] Kopp E., et al. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev 1999,13:2059-2071.
[14] Yang, R. B., Mark, M. R., Gurney, A. L. et al. (1999) Signaling events induced by lipopolysacharide-activated toll-like receptor 2. J. Immunol. 163,639-643.
[15] Irie, T., Muta, T., Takeshige, K. (2000) TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor- к B in lipopolysacharide-stimulated macrophages. FEBS Lett. 467,160-164.
[16] Matsumura T, Ito A, Takii T, et al. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 2000 Oct;20(10):915-21.
[17] Michael D. J., F. Rena B., Kunitaro F., et al. Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-α and not by Fas ligand. Am J Physiol Regulatory Integrative Comp Physiol. 2000,278:R1196-R1201.
[18] Murohisa G, Kobayashi Y, Kawasaki T, et al. Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin. Liver 2002 Oct;22(5):394-403
[19] Schoemaker MH, Res JE, Homan M, et al. Cytokine regulation of proand anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J Hepatol 2002 Jun;36(6):742-50.
[20] Zhao Y, Li S, Childs EE, et al. Activation of pro-death Bcl-2 family proteins and mitochondria apoptosis pathway in tumor necrosis factor-alpha-induced liver injury. J Biol Chem 2001 Jul 20;276(29):27432-40.
[21] C. Charles Barton, Eva X. Barton, Patricia E. Ganey, et al. Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor α. Hepatology 2001;33:66-73.
[22] Oberholzer A, Oberholzer C, Bah]at FR, et al. Genetic determinants of lipopolysaccharide and D-galactosamine-mediated hepatocellular apoptosis and lethality. J Endotoxin Res 2001;7(5):375-80.
[23] Garcia-Ruiz C, Colell A, Marl M, et al. Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout
mice. J Clin Invest 2003 Jan;111(2):197-208
[24] Maria T. Abreu, Puja Vora, Emmanuelle Faure, et al. Decreased expression of Toll-like receptor-4 and MD-2 corelates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 2001,167:1609-1617.
[25] Ekihiro seki, Hiroko Tsutsui, Hiroki Nakano, et al. Lipopolysaccharide-induced IL-18 secretion from murine Kuppffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-13. J. Immunol. 2001,166:2651-2657.
[26] Fumiko Nomura, et al. Cutting edge: Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J Immunol 2000,164:3476-3479.
[27] WiseMJ, LittlejohnTG, Humphery-SmithI. Peptide-mass fingerprinting and the ideal covering set for protein characterization. Electrophoresis, 1997,18(8):13995
[28] Michael D. J., F. Rena B., Kunitaro F., et al. Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-α and not by Fas ligand. Am J Physiol Regulatory Integrative Comp Physiol. 2000,278:R1196-R1201.
[29] Kinser S, Copple BL, Roth RA, et al. Enhancement of allyl alcohol hepatotoxicity by endotoxin requires extrahepatic factors. Toxicol Sci 2002 Oct;69(2):470-81
[30] Leonis MA, Toney-Earley K, Degen SJ, et al. Deletion of the Ron receptor tyrosine kinase domain in mice provides protection from endotoxin-induced acute liver failure. Hepatology 2002 Nov;36(5):1053-1060
[31] Sandra Steiner, Christine L., John J. Lennon, et al. Proteomics to display lovastatin-induced protein and pathway regulation in rat liver. Electrophoresis 2000,21,2129-2137.
[32] Dan Bach K., Norifumi K., Kunihiko I, et al. Proteome analysis of rat hepatic stellate cells. Hepatology 2000;32:268-277.
[33] Wu GS, Burns TF, Zhan Y, et al. Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Cancer Res 1999 Jun 15;59(12):2770-5
[34] Srivastava RK. TRAIL/Apo-2L: mechanisms and clinical applications in cancer. Neoplasia 2001 Nov-Dec;3(6):535-46
[35] Swift S, Blackburn C, Morahan G, et al. Structure and chromosomal mapping of the TNF-alpha inducible endothelial protein 1 (Edpl) gene in the mouse. Biochim Biophys Acta 1998 Nov 8;1442(2-3):394-8
[36] Abdul KM, Terada K, Vano M, et al. Functional analysis of human metaxin in mitochondrial protein import in cultured cells and its relationship with the Tom complex. Biochem Biophys Res Commun 2000 Oct 5;276(3):1028-34
[37] Xiaofei Wang, Koh Ono, Sung Ouk Kim, et al. Metaxin is required for tumor necrosis factor-induced cell death. EMBO reports 2001,2(7):628-633.
[38] Hofmann S, Rothbauer U, Muhlenbein N, et al. The C66W mutation in the deafness dystonia peptide 1 (DDP1) affects the formation of functional DDP1. TIM13 complexes in the mitochondrial intermembrane space. J Biol Chem 2002 Jun 28;277(26):23287-93
[39] Roesch K, Curran SP, Tranebjaerg L, et al. Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex. Hum Mol Genet 2002 Mar 1;11(5):477-86
[40] Keqiang Ye, Jun zhou, Jaren W. Landen, et al. Sustained activation of p34cdc2 is required for noscapine-induced apoptosis. Journal of Biological Chemistry. 2001 Dec,276(50):46697-46700.
[41] Song X, von Kampen J, Slaughter CA, et al. Relative functions of the alpha and beta subunits of the proteasome activator, PA28. J Biol Chem 1997Oct 31;272(44):27994-8000
[42] Khan S, van den Broek M, Schwarz K, et al. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J Immunol 2001 Dec 15;167(12):6859-68
[43] Selengut JD. MDP-1 is a new and distinct member of the haloacid dehalogenase family of aspartate-dependent phosphohydrolases. Biochemistry 2001 Oct 23;40(42):12704-11
[44] Aijun Wang, Christina A. Johnson, Ying Jones, et al. Subcellular localization and PKC-dependent regulation of the human lysophospholipase A/acy1-protein thioesterase in WISH cells. Biochim Biophysica Acta 1484 (2000)207-214.
[2] Takehiko Uesugi, Matthias Froh, GavinE. Arteel, et al. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology. 2001,34:101-108.
[3] Rock, G. Hardiman, J. C. Timans, et al. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA. 1998,95:588.
[4] Takeuchi, O. T. Kawwai, H. Sanjo, et al. TLR6:a novel member of an expanding Toll-like receptor family. Gene. 1999,231:59.
[5] Tatsushi Muta & Koichiro Takeshige Essential roles of CD14 and lipopolysacharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4. Eur. J. Biochem. 2001,268:4580-4589.
[6] Ruey-Bing Yang, Melanie R. mark, Alane Gray, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature. 1998,395:284-288.
[7] Poltorak, A. X. He, I. Smirnova, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutants in Tlr4 gene. Science 282:2085.
[8] Hoshino, K., Takeuchi, O., Kawai, T., et al. (1999) Toll-like receptor 4(TLR4)-deficient mice are hyporesponsive to lipopolysacharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162,3749-3752.
[9] Takeuchi, O., Hoshino, K., Kawai, T., et al. (1999) Differetial roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11,443-451.
[10] Muzio, M. et al. Differential expression and regulation of Toll-like receptors in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164,5998-6004(2000).
[11] Lena Alexopoulou, Agnieszka Czopik Holt, Ruslan Medzhitov, et al. (2001) Recognition of double-stranded RNA and activation of NF-к B by Toll-like receptor 3. Nature. 413:732-738.
[12] Burns K., ClatworthyJ., Martin L, et al. Tollip, a new component of the IL-R1 pathway, links IRAK to the IL-1 receptor. Nat Cell Biol 2000,2:346-351.
[13] Kopp E., et al. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev 1999,13:2059-2071.
[14] Yang, R. B., Mark, M. R., Gurney, A. L. et al. (1999) Signaling events induced by lipopolysacharide-activated toll-like receptor 2. J. Immunol. 163,639-643.
[15] Irie, T., Muta, T., Takeshige, K. (2000) TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor- к B in lipopolysacharide-stimulated macrophages. FEBS Lett. 467,160-164.
[16] Matsumura T, Ito A, Takii T, et al. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 2000 Oct;20(10):915-21.
[17] Michael D. J., F. Rena B., Kunitaro F., et al. Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-α and not by Fas ligand. Am J Physiol Regulatory Integrative Comp Physiol. 2000,278:R1196-R1201.
[18] Murohisa G, Kobayashi Y, Kawasaki T, et al. Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin. Liver 2002 Oct;22(5):394-403
[19] Schoemaker MH, Res JE, Homan M, et al. Cytokine regulation of proand anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J Hepatol 2002 Jun;36(6):742-50.
[20] Zhao Y, Li S, Childs EE, et al. Activation of pro-death Bcl-2 family proteins and mitochondria apoptosis pathway in tumor necrosis factor-alpha-induced liver injury. J Biol Chem 2001 Jul 20;276(29):27432-40.
[21] C. Charles Barton, Eva X. Barton, Patricia E. Ganey, et al. Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor α. Hepatology 2001;33:66-73.
[22] Oberholzer A, Oberholzer C, Bah]at FR, et al. Genetic determinants of lipopolysaccharide and D-galactosamine-mediated hepatocellular apoptosis and lethality. J Endotoxin Res 2001;7(5):375-80.
[23] Garcia-Ruiz C, Colell A, Marl M, et al. Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout
mice. J Clin Invest 2003 Jan;111(2):197-208
[24] Maria T. Abreu, Puja Vora, Emmanuelle Faure, et al. Decreased expression of Toll-like receptor-4 and MD-2 corelates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 2001,167:1609-1617.
[25] Ekihiro seki, Hiroko Tsutsui, Hiroki Nakano, et al. Lipopolysaccharide-induced IL-18 secretion from murine Kuppffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-13. J. Immunol. 2001,166:2651-2657.
[26] Fumiko Nomura, et al. Cutting edge: Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J Immunol 2000,164:3476-3479.
[27] WiseMJ, LittlejohnTG, Humphery-SmithI. Peptide-mass fingerprinting and the ideal covering set for protein characterization. Electrophoresis, 1997,18(8):13995
[28] Michael D. J., F. Rena B., Kunitaro F., et al. Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-α and not by Fas ligand. Am J Physiol Regulatory Integrative Comp Physiol. 2000,278:R1196-R1201.
[29] Kinser S, Copple BL, Roth RA, et al. Enhancement of allyl alcohol hepatotoxicity by endotoxin requires extrahepatic factors. Toxicol Sci 2002 Oct;69(2):470-81
[30] Leonis MA, Toney-Earley K, Degen SJ, et al. Deletion of the Ron receptor tyrosine kinase domain in mice provides protection from endotoxin-induced acute liver failure. Hepatology 2002 Nov;36(5):1053-1060
[31] Sandra Steiner, Christine L., John J. Lennon, et al. Proteomics to display lovastatin-induced protein and pathway regulation in rat liver. Electrophoresis 2000,21,2129-2137.
[32] Dan Bach K., Norifumi K., Kunihiko I, et al. Proteome analysis of rat hepatic stellate cells. Hepatology 2000;32:268-277.
[33] Wu GS, Burns TF, Zhan Y, et al. Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Cancer Res 1999 Jun 15;59(12):2770-5
[34] Srivastava RK. TRAIL/Apo-2L: mechanisms and clinical applications in cancer. Neoplasia 2001 Nov-Dec;3(6):535-46
[35] Swift S, Blackburn C, Morahan G, et al. Structure and chromosomal mapping of the TNF-alpha inducible endothelial protein 1 (Edpl) gene in the mouse. Biochim Biophys Acta 1998 Nov 8;1442(2-3):394-8
[36] Abdul KM, Terada K, Vano M, et al. Functional analysis of human metaxin in mitochondrial protein import in cultured cells and its relationship with the Tom complex. Biochem Biophys Res Commun 2000 Oct 5;276(3):1028-34
[37] Xiaofei Wang, Koh Ono, Sung Ouk Kim, et al. Metaxin is required for tumor necrosis factor-induced cell death. EMBO reports 2001,2(7):628-633.
[38] Hofmann S, Rothbauer U, Muhlenbein N, et al. The C66W mutation in the deafness dystonia peptide 1 (DDP1) affects the formation of functional DDP1. TIM13 complexes in the mitochondrial intermembrane space. J Biol Chem 2002 Jun 28;277(26):23287-93
[39] Roesch K, Curran SP, Tranebjaerg L, et al. Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex. Hum Mol Genet 2002 Mar 1;11(5):477-86
[40] Keqiang Ye, Jun zhou, Jaren W. Landen, et al. Sustained activation of p34cdc2 is required for noscapine-induced apoptosis. Journal of Biological Chemistry. 2001 Dec,276(50):46697-46700.
[41] Song X, von Kampen J, Slaughter CA, et al. Relative functions of the alpha and beta subunits of the proteasome activator, PA28. J Biol Chem 1997Oct 31;272(44):27994-8000
[42] Khan S, van den Broek M, Schwarz K, et al. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J Immunol 2001 Dec 15;167(12):6859-68
[43] Selengut JD. MDP-1 is a new and distinct member of the haloacid dehalogenase family of aspartate-dependent phosphohydrolases. Biochemistry 2001 Oct 23;40(42):12704-11
[44] Aijun Wang, Christina A. Johnson, Ying Jones, et al. Subcellular localization and PKC-dependent regulation of the human lysophospholipase A/acy1-protein thioesterase in WISH cells. Biochim Biophysica Acta 1484 (2000)207-214.